Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer. - Wikidata - wikimedia - TriplyDB

Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer.

Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer.

http://www.wikidata.org/entity/Q30427989

about

Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challenges CXCR2: a target for pancreatic cancer treatment?Exploiting inflammation for therapeutic gain in pancreatic cancer Solution Structure of CXCL5 — A Novel Chemokine and Adipokine Implicated in Inflammation and Obesity Immune checkpoint and inflammation as therapeutic targets in pancreatic carcinoma Macrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis.CXCR2 signaling regulates KRAS(G¹²D)-induced autocrine growth of pancreatic cancer.CXCL5 as a potential novel prognostic factor in early stage non-small cell lung cancer: results of a study of expression levels of 23 genes.The role of chemoattractant receptors in shaping the tumor microenvironment.The emerging role of CXC chemokines and their receptors in cancer.Plasma cytokine concentrations indicate that in vivo hormonal regulation of immunity is altered during long-duration spaceflight.A novel statistical prognostic score model that includes serum CXCL5 levels and clinical classification predicts risk of disease progression and survival of nasopharyngeal carcinoma patients.Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes.Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies.Expression of interleukin-8 receptor CXCR2 and suppressor of cytokine signaling-3 in astrocytic tumors.A KSHV microRNA enhances viral latency and induces angiogenesis by targeting GRK2 to activate the CXCR2/AKT pathway.Pro-oncogenic cytokines and growth factors are differentially expressed in the post-surgical wound fluid from malignant compared to benign breast lesions CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma.Role of bone marrow-derived cells in angiogenesis: focus on macrophages and pericytes.The Chinese medicine JC-001 enhances the chemosensitivity of Lewis lung tumors to cisplatin by modulating the immune response CXCR2 macromolecular complex in pancreatic cancer: a potential therapeutic target in tumor growth Curcumin suppresses NTHi-induced CXCL5 expression via inhibition of positive IKKβ pathway and up-regulation of negative MKP-1 pathway.Androgen receptor (AR) signaling promotes RCC progression via increased endothelial cell proliferation and recruitment by modulating AKT → NF-κB → CXCL5 signaling.Chemokines, chemokine receptors and the gastrointestinal system.The immune network in pancreatic cancer development and progression.Molecular Basis of Chemokine CXCL5-Glycosaminoglycan Interactions CXCL5 stimulation of RANK ligand expression in Paget's disease of bone.Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases.Identification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblasts.CXCL5 is a potential diagnostic and prognostic marker for bladder cancer patients.Lymph node metastasis and the physicochemical micro-environment of pancreatic ductal adenocarcinoma xenografts.CXCR2-Dependent Accumulation of Tumor-Associated Neutrophils Regulates T-cell Immunity in Pancreatic Ductal Adenocarcinoma.Insulin Receptor and GPCR Crosstalk Stimulates YAP via PI3K and PKD in Pancreatic Cancer Cells.KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops.The clinical significance of CXCL5 in non-small cell lung cancer.Human papillomavirus oncogenes reprogram the cervical cancer microenvironment independently of and synergistically with estrogen.Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma.Melanoma exosomes promote mixed M1 and M2 macrophage polarization.CXCL5 secreted from adipose tissue-derived stem cells promotes cancer cell proliferation.

P2860

Q26866236-037CD28C-E8B5-4640-8334-AA95699C28D1 Q27021588-CA6858FC-5015-45C6-A686-50A1CA0EBDA6 Q27027661-F7ABA722-37BC-4AA6-A85D-31E70E68EDCD Q27682811-293CE8F2-F9DE-4CAF-A7B3-608CF6CC5E4A Q28069864-7664CC03-5C5E-4FEC-8FD0-470E2462AEBF Q30278005-1BF67E47-346F-4376-93E4-1BC202F5B7AE Q30358993-1D7F4CCD-A10E-4E85-80BE-680D7EBDC39C Q33562564-F8A9FDDD-0953-4988-B066-4F2CD457DE08 Q33993124-AA11A0E3-D809-4696-AB54-81219510F9E9 Q34263645-9022BBA8-FA62-4306-AEC1-2E9F92B484DB Q34294091-7016819F-B823-4236-9427-21665CAC6E34 Q34612497-A20E2725-5B1C-49F4-995B-55420B3A730E Q35498810-EB5D3E63-AC70-42A3-AFAC-AA4C6CE429EC Q35934127-6B3AC561-8A98-42EF-B7B7-62E93FF9B3C8 Q35973308-ABEA0B15-658C-4C6E-B322-06D5F41A7CA9 Q35983671-8CDBB849-7676-4CCE-A9C7-4EF385FABC7A Q36029913-9FD4E763-C991-4B2C-9661-CC0109CD9353 Q36041701-2BFBD766-84F4-4DA0-A9EE-BA87CABC55C3 Q36284948-9C6DAFB1-E1F3-4740-977C-AF03AAE1018E Q36343870-3B974523-F381-4FEF-9BC1-1C980C6268BF Q36723785-A118173D-D997-42A7-9EF0-FF9FB05D2E88 Q37188938-B20C1440-32DB-489B-AF8A-2969A6612656 Q37416749-D83A8996-B0A3-4AAE-AFED-C43E64438D09 Q38109160-FAB98C00-120F-4798-84A0-37B6E81EBB42 Q38121412-42C8E0F3-086A-4458-B994-CDBCBB78AC2D Q38291506-E6CEBC3A-1DB5-4649-B701-49AC0398AF3D Q39188901-42C9D761-048C-48B3-BE33-974FC4B5D970 Q39246205-F7BC2A0F-AE8C-4BC0-AA14-99DE86A5C49E Q39321350-F8A39D5A-7C88-4313-BE20-ACC2687EDBC7 Q39396200-68EDF67C-A81B-4A92-837E-2F329495B1D1 Q40936667-5A4AF569-486D-4523-AC54-DE3A3D85A91C Q41471434-17A6F324-F3C3-46E0-9DE2-67AA9F44503E Q42697314-4EB01AD7-BE78-492D-BC37-5001A52D667E Q46302561-FA8FE27E-FACD-402B-B150-0F4DFA0C2E3E Q46471150-DE8FAEE8-FF33-437D-A666-29E52A19C1AA Q47101861-2CCA4279-96EE-4E71-B4E8-B3AA87E08681 Q47407749-FB45460A-90D5-42C6-8FF8-11571CCB7D67 Q48583884-B67CA5EB-3215-474A-AAF6-22EFF7CD3F58 Q49833213-D54F16F4-BBB8-40AF-82ED-44F1A0B7A682 Q50040819-34A4243B-49DE-40EE-8193-B422F0412143

P2860

Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer.

http://www.wikidata.org/entity/Q30427989

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Overexpression of CXCL5 is ass ...... tients with pancreatic cancer.

@ast

Overexpression of CXCL5 is ass ...... tients with pancreatic cancer.

@en

type

label

Overexpression of CXCL5 is ass ...... tients with pancreatic cancer.

@ast

Overexpression of CXCL5 is ass ...... tients with pancreatic cancer.

@en

prefLabel

Overexpression of CXCL5 is ass ...... tients with pancreatic cancer.

@ast

Overexpression of CXCL5 is ass ...... tients with pancreatic cancer.

@en

P1433

Q30427989-1E5906DF-BC74-4AC6-B875-251858BA81C5

P1476

Q30427989-9D5E8BA2-3C93-4EA9-B107-971A7C598129

P2093

Q30427989-0ADA3171-1C60-4118-8366-FE58A6BD9C5E

Q30427989-118F377C-C3A9-4AF1-B0E1-977928198A34

Q30427989-2683ED7E-5C91-407B-9A4D-5CE2CF2411D8

Q30427989-394F3CE5-E359-4598-995A-DA6F3BEDE9F2

Q30427989-7B737136-9A59-4F9C-BD0B-3620A31AE507

Q30427989-88D6BA34-2027-402F-B98A-3D5669D2D461

Q30427989-93F056D0-3888-4AB4-880A-4000A364DB34

Q30427989-A3ACD3A3-F5BE-4DD1-B815-3E635D690575

Q30427989-BD12D8E9-7B16-41B1-A165-CBC9C86B9848

Q30427989-BE2F8CFB-4F74-480E-8ECF-1FD626B34061

P2860

Q30427989-006131D5-745E-4973-83E1-D1A50D7DA6D8

Q30427989-070A1778-65E7-429E-8200-74F0A2E94A07

Q30427989-0993E97D-1A50-4B69-9EC9-285940157044

Q30427989-108FC7C0-1C3D-419E-BADE-DE5C2A170E7E

Q30427989-13BE2DCB-4A2A-4B9F-BC72-52341E6A4953

Q30427989-268FD06E-4298-4540-B328-E74A5D360322

Q30427989-32AA4C26-1DF1-4832-864C-82680BA6D70B

Q30427989-3EC32B0A-65FF-432C-B2E5-A812B30C2AB3

Q30427989-42F1760B-2A7F-48E8-B1DC-03D3B7381774

Q30427989-4D1C160D-D94B-4BCA-8CFE-98CCFA90DE06

P304

Q30427989-3442B736-7D81-4234-BE3F-14122C8D5EAE

P31

Q30427989-4EB5F0D6-BEFF-460D-8125-5018EAC7CBAB

P356

Q30427989-405189AD-9B65-477B-94CA-90292570FE7E

P407

Q30427989-73A6CD81-B383-4C50-96CB-8C5957F2FCF3

P433

Q30427989-E4668090-CA2E-4199-8D26-4E0F1DF0608B

P478

Q30427989-EF8487C1-B3AC-462D-A9D1-A7EDFBCD934E

P577

Q30427989-FFCC6558-B56E-4342-B885-BC8E21D4560F

P5875

Q30427989-9AEBD8B9-70F4-49C9-B5E9-5AB60AABCB69

P698

Q30427989-4E592BE8-A58B-4230-A6ED-D6C237DC4903

P921

Q30427989-EBD4326C-7811-4ECD-A9C4-67C1E13941E3

P932

Q30427989-73415038-3B79-413D-9760-95DE1947DE7A

P356

J.AJPATH.2010.11.058

P1433

The American Journal of Pathology

P1476

Overexpression of CXCL5 is ass ...... tients with pancreatic cancer.

@en

P2093

Aihua Li

http://www.w3.org/2001/XMLSchema#string

Aune Moro

http://www.w3.org/2001/XMLSchema#string

David W Dawson

http://www.w3.org/2001/XMLSchema#string

Gang Li

http://www.w3.org/2001/XMLSchema#string

Guido Eibl

http://www.w3.org/2001/XMLSchema#string

Howard A Reber

http://www.w3.org/2001/XMLSchema#string

Jeffrey Kaplan

http://www.w3.org/2001/XMLSchema#string

Jonathan King

http://www.w3.org/2001/XMLSchema#string

Marie Burdick

http://www.w3.org/2001/XMLSchema#string

Mark D Sugi

http://www.w3.org/2001/XMLSchema#string

P2860

Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis

Delayed wound healing in CXCR2 knockout mice

Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo

Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8

Cancer statistics, 2008

Cancer statistics, 2009

The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity.

CXC chemokines in angiogenesis.

Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation.

Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions.

P304

1340-1349

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AJPATH.2010.11.058

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

178

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50225511

http://www.w3.org/2001/XMLSchema#string

P698

21356384

http://www.w3.org/2001/XMLSchema#string

P921

P932

3069811

http://www.w3.org/2001/XMLSchema#string